Search

Your search keyword '"treatment cycles"' showing total 1 results
Start Over Descriptor "treatment cycles" Topic inotuzumab ozogamicin
1 results on '"treatment cycles"'

1. Impact of number of cycles on outcomes of patients with relapsed or refractory acute lymphoblastic leukaemia treated with inotuzumab ozogamicin.

Author

Cassaday RD, Marks DI, DeAngelo DJ, Jabbour EJ, Advani AS, O'Brien S, Wang T, Neuhof A, Vandendries E, Kantarjian HM, Stock W, and Stelljes M

Subjects
Antineoplastic Agents, Immunological administration & dosage, Antineoplastic Agents, Immunological adverse effects, Combined Modality Therapy, Drug Resistance, Neoplasm, Humans, Inotuzumab Ozogamicin administration & dosage, Inotuzumab Ozogamicin adverse effects, Precursor Cell Lymphoblastic Leukemia-Lymphoma diagnosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma mortality, Prognosis, Recurrence, Remission Induction, Retreatment, Treatment Outcome, Antineoplastic Agents, Immunological therapeutic use, Inotuzumab Ozogamicin therapeutic use, Precursor Cell Lymphoblastic Leukemia-Lymphoma drug therapy
Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results